Mireille Kamariza

University Of California Los Angeles

$1,401,354

Attributed

$1,401,354

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $675.2K · FY2017–25

$1M$750K$500K$250K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$1,401,354 · 2

By mechanism

R01$1,312,786 · 1

F31$88,568 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Protocols Documentation”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
Kimberly Smith · Ppd Development Lp$115,671,664
Yunda Huang · Fred Hutchinson Cancer Center$72,098,149
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$62,652,398

Research focus

Protocols DocumentationTuberculosisMetabolicProgramsSputumTrehaloseFluorescenceLabelMycobacterium TuberculosisPoint Of CareResourcesSpecificityDiagnosisDiagnosticBacteriaDrug ResistanceInfectionIn VitroDesignCountryPerformancePharmaceutical PreparationsResistant StrainTuberculosis Drugs

Grant awards (4)

A Rapid Phenotypic Drug Susceptibility Testing System for Tuberculosis$637,630

R01 · FY2025 · AI · contact PI

A Rapid Phenotypic Drug Susceptibility Testing System for Tuberculosis$675,156

R01 · FY2024 · AI · contact PI

Investigating a fluorogenic DMN-trehalose conjugate as a novel detection tool for Mycobacterium tuberculosis$44,524

F31 · FY2018 · AI · contact PI

Investigating a fluorogenic DMN-trehalose conjugate as a novel detection tool for Mycobacterium tuberculosis$44,044

F31 · FY2017 · AI · contact PI